Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · November 13, 2023

Rosuvastatin vs Atorvastatin Treatment in Adults With Coronary Artery Disease

BMJ: British Medical Journal


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ: British Medical Journal
Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
BMJ 2023 Oct 18;383(xx)e075837, YJ Lee, SJ Hong, WC Kang, BK Hong, JY Lee, JB Lee, HJ Cho, J Yoon, SJ Lee, CM Ahn, JS Kim, BK Kim, YG Ko, D Choi, Y Jang, MK Hong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading